CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing
Why the fresh vs cryo decision matters Most CAR T processes are built around predictable inputs. When those inputs shift, it becomes harder to hit target yields, expansion timing, and manufacturing release criteria. Fresh and cryopreserved leukopaks differ in: logistics and scheduling flexibility post processing recovery and expansion behavior sensitivity to handling variables lot to lot consistency Choosing the right format is not about “which is better.” It is about what your process and program stage require. Fresh leukopaks Best for workflows…
Armored CAR T
Strengthening T Cells for the Toughest Tumors CAR T therapy changed what is possible in blood cancers. But solid tumors remain one of the toughest frontiers in oncology. Not because we do not know what to target.Because the tumor environment fights back. Solid tumors suppress immune activity, block infiltration, and exhaust T cells before they can finish the job. That is why the next chapter of CAR T is not only about recognition. It is about survival, persistence, and control inside hostile…
Best CD34+ Cell Suppliers for 2026: Comparing Bone Marrow, Cord Blood, and Mobilized Sources
Introduction CD34+ hematopoietic stem and progenitor cells are critical to cell therapy development, gene editing workflows, and translational immunology research. Whether sourced from bone marrow, mobilized peripheral blood, or cord blood, CD34 cell quality and documentation directly influence downstream expansion, differentiation, and functional outcomes. In 2026, research teams are evaluating suppliers based not only on availability, but also on donor screening transparency, isolation methodology, documentation standards, and logistical reliability. This comparison reviews leading CD34 cell suppliers serving academic, biotech, and translational research…
Best Mobilized Leukopak Suppliers for 2026: G-CSF vs. Plerixafor Compared
Introduction Mobilized leukopaks are essential starting material for advanced cell therapies, immune research, and manufacturing optimization. By mobilizing hematopoietic stem and progenitor cells (HSPCs) from the bone marrow into the bloodstream using agents like G-CSF or plerixafor, researchers can isolate higher yields of CD34+ and target immune cells for CAR T, NK, and other immunotherapy platforms. To understand how mobilization enhances yield and performance, see our detailed guide on Mobilized Leukopaks for Research. As demand for high-yield, donor-characterized, and recallable leukopaks grows,…
Optimizing PBMC Viability and Recovery: Updated Best Practices for 2026
In biomedical research, the viability and recovery of peripheral blood mononuclear cells (PBMCs) determine the reliability of downstream results. Over the past few years, advances in donor screening, cryopreservation, and logistics have dramatically improved the consistency of primary immune cell performance. Yet, small variables—temperature shifts, prolonged DMSO exposure, or donor differences—still account for major discrepancies in experimental reproducibility. At CGT Global, we continuously evaluate the factors that most influence PBMC quality to help researchers obtain high-viability, high-recovery results from every sample. This…
Meet CGT Global’s Scientific Team: Sophia Johnson Associate Director of Logistic OperationsÂ
For cell procurement and delivery operations to run smoothly, countless moving parts must align. From understanding the needs of a research project to scheduling donors, fulfilling orders, and ensuring precise delivery, every step must fit together seamlessly. So, who keeps everything ticking like a perfectly timed clock? Meet Sophia Johnson, Associate Director of Logistic Operations at CGT Global. Sophia has been with CGT Global for 6 years, bringing her background in psychology and a talent making the puzzle pieces fit applying her expert planning and organization skills. While at Sonoma State, Sophia…
Scaling Humanized Immune System Mouse Models: Optimize Your CD34+ Engraftment with High Quality Cells
Table of contents Key Takeaways CD34+ humanized mice enable better predictions for therapies, reducing the translational gap between humans and mice. High-quality CD34+ cells from CGT Global enhance engraftment success rates for HIS mice in preclinical studies. Cell viability, purity, and accurate counts are crucial for consistent and predictive data from these models. Ordering bulk CD34+ cells can significantly reduce costs and improve experimental workflows for researchers. CGT Global offers customized solutions and resources to support scientists in their CD34+ cell sourcing…
Top PBMC Suppliers for 2026: Fresh, Cryopreserved, and GMP-Grade Options Compared
Introduction Peripheral Blood Mononuclear Cells (PBMCs) are foundational to immunology, oncology, and cell therapy research. Whether they are used for functional assays, vaccine development, or discovery-stage therapeutic studies, PBMC quality directly impacts data accuracy and reproducibility. In 2026, researchers expect more than just availability. They look for documented donor screening, consistent viability, and responsive support. This comparison reviews the top PBMC suppliers serving academic, biotech, and translational research programs, focusing on quality, logistics, and communication. Disclosure: This comparison was developed by CGT…
Best Leukopak Suppliers for Cell Therapy in 2026: Pricing, Quality, and Turnaround Compared
Introduction When it comes to sourcing leukopaks for cell therapy or research, product quality is only half the story. Procurement delays, unanswered inquiries, and limited visibility can stall entire workflows. In 2026, speed and communication matter just as much as purity and yield. To help researchers, process developers, and procurement teams choose confidently, we reviewed leading leukopak suppliers on quality metrics, mobilization options, GMP compliance and increasingly – responsiveness. “This comparison was written by CGT Global, a supplier of leukopaks and related…
The Donors Powering Breakthroughs in Maternal and Infant Health
Become a Donor 📞 Call or Text (916) 350-0714 Every great discovery begins with a volunteer. At CGT Global, maternal blood donors are at the heart of pregnancy and infant health research. Their contributions help scientists understand how life begins, how the body adapts during pregnancy, and how to prevent complications that still threaten mothers and babies worldwide. When someone donates maternal blood, they are not just giving a sample. They are giving researchers a glimpse into one of the most complex and…
Scaling Cell & Gene Therapy Development: How CGT Global Supports Research, Clinical Trials, and Commercialization
By Joanna Wirkus, PhD From RUO to cGMP, CGT Global delivers quality, consistency, and regulatory readiness to help researchers advance therapies from discovery to patients. Executive Summary CGT Global accelerates cell and gene therapy development from discovery to commercialization. By providing rapid and reliable access to high-quality RUO and cGMP-certified materials and operating FDA- and CLIA-certified clinics co-located with cell specific labs, CGT Global ensures speed, consistency, and regulatory-ready CMC packages. This integration helps sponsors avoid delays, streamline clinical trials, and expand patient…
Meet CGT Global’s Scientific Team: Vanessa Murillo – Supervisor, Client Scientific Associate Team
October 08, 2025 Written by: Joanna Wirkus, PhD At CGT Global, advancing scientific discoveries worldwide by delivering high-quality biospecimens starts with providing exceptional service to our clients. Today, we’re highlighting how this happens by speaking with Vanessa Murillo, a core member and leader of CGT Global’s Client Scientific Associate team. Vanessa is a Client Scientific Associate Supervisor based in Reno, Nevada. Her and her team are dedicated to the success of CGT Global’s scientific partners and collaborators. Vanessa attended the University of…